CARAMORI, Gaetano
 Distribuzione geografica
Continente #
NA - Nord America 3.766
EU - Europa 2.771
AS - Asia 1.891
OC - Oceania 4
Totale 8.432
Nazione #
US - Stati Uniti d'America 3.759
IE - Irlanda 1.421
CN - Cina 1.120
SG - Singapore 676
SE - Svezia 575
IT - Italia 494
PL - Polonia 92
DE - Germania 73
IN - India 50
FI - Finlandia 25
GB - Regno Unito 22
BE - Belgio 20
VN - Vietnam 14
FR - Francia 13
RU - Federazione Russa 11
ID - Indonesia 8
AT - Austria 7
CA - Canada 7
TW - Taiwan 5
AU - Australia 4
GR - Grecia 4
NL - Olanda 4
CZ - Repubblica Ceca 3
TR - Turchia 3
UA - Ucraina 3
BG - Bulgaria 2
HK - Hong Kong 2
IR - Iran 2
JP - Giappone 2
KR - Corea 2
MY - Malesia 2
PH - Filippine 2
BY - Bielorussia 1
IQ - Iraq 1
RO - Romania 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 8.432
Città #
Dublin 1.421
Chandler 541
Singapore 523
Dearborn 509
Nyköping 399
Princeton 327
Beijing 310
Jacksonville 266
Des Moines 232
San Mateo 224
Cambridge 219
Ashburn 186
Messina 175
Medford 168
Jinan 116
Shenyang 109
Warsaw 92
Nanjing 61
Wilmington 59
Ningbo 58
Tianjin 57
Zhengzhou 52
Ann Arbor 48
Hebei 47
Bremen 46
Haikou 39
Lanzhou 38
Nanchang 38
Pune 37
Hangzhou 31
Taizhou 28
Rome 25
Naples 22
New York 20
Brussels 19
Fuzhou 19
Milan 19
The Dalles 19
Guangzhou 18
Jiaxing 17
Los Angeles 16
Changsha 15
Cassino 14
Dong Ket 14
Munich 14
Norwalk 13
Seattle 12
Falls Church 11
Helsinki 11
Turin 9
Jakarta 7
Saint Petersburg 7
Bari 6
Hyderabad 6
Boardman 5
Lancaster 5
Lappeenranta 5
Mountain View 5
New Delhi 5
Ottawa 5
Taiyuan 5
Taranto 5
Vienna 5
Fairfield 4
Hefei 4
Houston 4
Kunming 4
London 4
Mineo 4
Padova 4
Redmond 4
San Giuliano Terme 4
The Bronx 4
Washington 4
Aci Bonaccorsi 3
Adelaide 3
Birmingham 3
Brescia 3
Brno 3
Cagliari 3
Canicattì 3
Capannori 3
Castenaso 3
Cossato 3
Espoo 3
Florence 3
Grandate 3
Iowa City 3
Lesignano de' Bagni 3
Paros 3
Piazza Armerina 3
Redwood City 3
Speyer 3
Wuhan 3
Ancona 2
Aragona 2
Bologna 2
Brooklyn 2
Catania 2
Chang-hua 2
Totale 6.950
Nome #
HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk 132
Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD 89
Molecular links between COPD and lung cancer: new targets for drug discovery? 81
Hereditary hyperhomocysteinemia associated with nephrotic syndrome complicated by artery thrombosis and chronic thromboembolic pulmonary hypertension: A case report 78
Trattamento personalizzato dei pazienti con BPCO in fase stabile [Personalised treatment of stable COPD patients] 75
Polmonite interstiziale fibrosante da amiodarone 73
TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD 70
Role of Stem Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Pulmonary Emphysema 69
Functional role of inflammasome activation in a subset of obese nonsmoking patients with severe asthma 67
Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression. 65
Asthma under/misdiagnosis in primary care setting: An observational community-based study in Italy 65
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 64
Autoimmunity and COPD: Clinical Implications 58
An unusual cause of chest pain 53
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis 53
Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD 52
Posttranscriptional Gene Regulatory Networks in Chronic Airway Inflammatory Diseases: In silico Mapping of RNA-Binding Protein Expression in Airway Epithelium 52
Bacterial infections in the lungs of patients with systemic autoimmune diseases 52
Controllo della broncopneumopatia cronica ostruttiva in Italia 52
Role of Atypical Chemokines and Chemokine Receptors Pathways In the Pathogenesis of COPD 52
2 agonisti inalatori nel trattamento dell’asma bronchiale e delle broncopneumopatie croniche ostruttive. 51
Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine 51
AN UNUSUAL CASE OF CHRONIC AIRFLOW OBSTRUCTION IN A HEAVY SMOKER 51
Anatomia e fisiologia clinica della pleura. 50
Allergen Responses Modified by a GATA3 DNAzyme 50
Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines 50
Role of the mucins in pathogenesis of COPD: implications for therapy 49
Ultrasound assessment of diaphragm function in patients with late-onset Pompe disease 49
Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype? 49
Attuali progressi nel trattamento dell’asma bronchiale nell’adulto. 47
Asma. 47
Activation of NF-kappaB transcription factor in asthma death 47
Transcription inhibitors and inflammatory cell activity 47
D-dimer value in the diagnosis of pulmonary embolism — May it exclude only? 47
Differential diagnosis between newly diagnosed asthma and chronic obstructive pulmonary disease using exhaled breath condensate metabolomics: a pilot study 47
OXIDANTS AND ANTIOXIDANTS | Antioxidants, Nonenzymatic 47
Anti-inflammatory mechanisms of glucocorticoids targeting granulocytes. 46
Rischio di polmonite durante trattamenti regolari a lungo termine con glucocorticoidi inalatori nei pazienti con BPCO stabile: Revisione sistematica della letteratura 45
Commentary on "Major Complications Associated with Conventional Transbronchial Needle Aspiration" 45
Asma. 44
Asthma death. 44
Anti-inflammatory treatments for asthma: past, present, future. 43
Asthma is not a common cause of severe chronic respiratory failure in non-smokers: ALOT study. 43
The anti-proliferative and anti-inflammatory response of COPD airway smooth muscle cells to hydrogen sulfide 43
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. 43
Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease 42
Airway obstruction in chronic obstructive pulmonary disease. 41
Interferonopathy: A potential link between innate immunity and autoimmunity in the pathogenesis of COPD 41
A case of fibrosing interstitial pneumonia 41
Asthma: a chronic infectious disease? 40
Gender differences in COPD management in a Sicilian general practice setting: a cohort study evaluating the impact of educational interventions 40
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 39
Anti-inflammatory inhibitors of IkappaB kinase in asthma and COPD 39
New drugs under development for COPD 39
Adiponectin is Associated with Neutrophils to Lymphocyte Ratio in Patients with Chronic Obstructive Pulmonary Disease 39
Malattie virali dell’apparato respiratorio 38
Studio clinico-epidemiologico sulle neoplasie polmonari maligne. Confronto tra 2 coorti di pazienti nei quinquenni 1981-5 e 1991-5. 38
[Risk of diabetes mellitus during regular long-term inhaled glucocorticoid treatment in COPD patients: narrative review of the literature.] 38
Corticosteroid resistance in asthma: Cellular and molecular mechanisms 38
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease 37
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 37
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper 37
Epithelial Posttranscriptional Gene Regulatory Networks In Chronic Airway Inflammation: In Silico Mapping Of RNA-Binding Protein Expression 36
Treatable traits in COPD patients 36
Long-term use of inhaled glucocorticoids in patients with stable chronic obstructive pulmonary disease and risk of bone fractures: a narrative review of the literature 36
Evaluation of Innate Immune Mediators Related to Respiratory Viruses in the Lung of Stable COPD Patients 36
Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients 36
FN3K expression in COPD: A potential comorbidity factor for cardiovascular disease 36
COPD immunopathology 35
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients 35
Stato dell’arte degli antileucotrienici nella terapia dell’asma. 35
Polmoniti da parassiti 35
Birbeck granules: contribution to the comprehension of intracytoplasmic evolution. 35
A case of lung injury resembling diffuse pulmonary hemorrhage after the first administration of alemtuzumab in a patient with multiple sclerosis. Role of the HRCT 35
An unusual cause of dyspnoea in a patient with chronic ischemic heart disease 35
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 34
Morte per asma. Parte I: fenotipi clinici, epidemiologia e fattori di rischio. 34
Sport e inquinamento atmosferico 34
Methotrexate in the treatment of systemic glucocorticoid dependent severe persistent astma: a word of caution. 34
A microRNA-21-mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis 33
Immunomodulatory effect of gefitinib in epidermal growth factor receptor tyrosine kinase inhibitors sensitive and resistant Non small cell lung cancer: role of the RNA binding protein HuR 33
La teofillina nella BPCO: nuove prospettive (3° parte). 32
Targeting Th2 cells in asthmatic airways 32
Versamento ed empiema pleurico parapneumonico nell’adulto 32
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 32
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 31
Gli antagonisti dei leucotrieni: nuove speranze nella terapia dell'asma? 31
Oxidative Stress-induced Antibodies to Carbonyl-modified Protein Correlate with Severity of Chronic Obstructive Pulmonary Disease 31
A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. 31
Breaking news: DNA damage and repair pathways in COPD and implications for pathogenesis and treatment 31
Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6 31
La scoperta dell’ossido nitrico endogeno ha aperto nuove prospettive terapeutiche nella patologia polmonare dell’adulto? 30
Teofillina: effetti polmonari ed extrapolmonari nei pazienti con asma e BPCO; nuove prospettive. 29
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease. 29
Donna non fumatrice con asma bronchiale difficile da controllare. 29
Pulmonary vasculitis: classification, clinical features and management. 29
null 29
Broncodilatatori nella terapia delle broncopneumopatie croniche ostruttive. 28
Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. 28
Le linee guida vengono seguite? 28
Totale 4.427
Categoria #
all - tutte 52.720
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.720


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020909 0 0 0 0 3 443 112 26 34 191 85 15
2020/20211.371 19 19 710 21 277 8 14 91 83 59 44 26
2021/20221.672 5 65 5 273 27 13 181 87 21 73 336 586
2022/20232.907 368 189 104 152 134 184 35 96 1.557 8 52 28
2023/2024871 53 81 54 86 71 170 24 31 5 27 11 258
2024/2025619 74 28 80 314 123 0 0 0 0 0 0 0
Totale 8.952